Comparison of dietary phosphate absorption after single doses of lanthanum carbonate and sevelamer carbonate in healthy volunteers: A balance study

American Journal of Kidney Diseases

Volumn 57, Issue 5, 2011, Pages 700-706

  Martin, Patrick ^a   Wang, Phillip ^a   Robinson, Antoine ^a   Poole, Lynne ^b   Dragone, Jeffrey ^a   Smyth, Michael ^b   Pratt, Raymond ^a  

^a SHIRE   (United States)

^b Shire Pharmaceuticals   (United Kingdom)

Author keywords

Chronic kidney disease; clinical trial; lanthanum carbonate; phosphate binder; sevelamer carbonate

Indexed keywords

LANTHANUM CARBONATE; PHOSPHATE; PHOSPHORUS; SEVELAMER CARBONATE;

ADULT; ARTICLE; ATOMIC EMISSION SPECTROMETRY; CHEMICAL COMPOSITION; COMPARATIVE STUDY; CONTROLLED STUDY; CROSSOVER PROCEDURE; DATA ANALYSIS; DIET RESTRICTION; DIZZINESS; DRUG ERUPTION; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EFFLUENT; FEMALE; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL TRANSIT; HUMAN; HYPERPHOSPHATEMIA; MALE; MEAL; NAUSEA; NORMAL HUMAN; OPEN STUDY; OUTCOME ASSESSMENT; PHARMACODYNAMICS; PHOSPHATE ABSORPTION; PHOSPHATE METABOLISM; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; TABLET; VOLUNTEER; VOMITING;

ADULT; CHELATING AGENTS; CROSS-OVER STUDIES; FEMALE; HUMANS; INTESTINAL ABSORPTION; LANTHANUM; MALE; MIDDLE AGED; PHOSPHORUS, DIETARY; POLYAMINES; YOUNG ADULT;

EID: 79954568533     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2010.11.028     Document Type: Article

References (32)

1. G.A. Block, P.S. Klassen, and J.M. Lazarus Mineral metabolism, mortality, and morbidity in maintenance hemodialysis J Am Soc Nephrol 15 2004 2208 2218 (Pubitemid 39031360)
2. B. Kestenbaum, J.N. Sampson, and K.D. Rudser Serum phosphate levels and mortality risk among people with chronic kidney disease J Am Soc Nephrol 16 2005 520 528 (Pubitemid 41725150)
3. M.D. Danese, V. Belozeroff, K. Smirnakis, and K.J. Rothman Consistent control of mineral and bone disorder in incident hemodialysis patients Clin J Am Soc Nephrol 3 2008 1423 1429
4. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD) Kidney Int 76 suppl 113 2009 S1 S130
5. G. Eknoyan, A. Levin, and N.W. Levin Bone metabolism and disease in chronic kidney disease Am J Kidney Dis 42 2003 1 201
6. Dialysis Outcomes and Practice Patterns Study Investigators Serum phosphate (categories), by DOPPS country and cross-section 2009 Annual Report of the Dialysis Outcomes and Practice Patterns Study: Hemodialysis Data 1999-2008 Ann Arbor, MI: Arbor Research Collaborative for Health http://www.dopps.org/ annualreport/html/qphosphmgdl-c-TAB2009.htm Accessed June 17, 2010
7. C.S. Shinaberger, S. Greenland, and J.D. Kopple Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease? Am J Clin Nutr 88 2008 1511 1518
8. National Kidney Foundation Kidney Disease Outcomes Quality Initiative Guideline 15. Dietary protein intake (DPI) in maintenance hemodialysis (MHD). Clinical Practice Guidelines for Nutrition in Chronic Renal Failure (2000) http://www.kidney.org/professionals/kdoqi/guidelines-updates/nut-a15.html Accessed May 27, 2010
9. J.A. Ramirez, M. Emmett, and M.G. White The absorption of dietary phosphorus and calcium in hemodialysis patients Kidney Int 30 1986 753 759 (Pubitemid 17049596)
10. 3): an efficient and safe phosphate binder in haemodialysis patients? A 3-year study Nephrol Dial Transplant 8 1993 530 534 (Pubitemid 23199488)
11. G.A. Block, D.M. Spiegel, and J. Ehrlich Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis Kidney Int 68 2005 1815 1824 (Pubitemid 43169927)
12. ®) on coronary artery calcification (CAC) and endothelial function (FMD) in hemodialysis (HD) patients A pilot, prospective study [ASN abstract F-PO1252] J Am Soc Nephrol 20 2009 399A
13. D. Russo, I. Miranda, and C. Ruocco The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer Kidney Int 72 2007 1255 1261 (Pubitemid 350059663)
14. G.M. Chertow, S.K. Burke, and P. Raggi Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients Kidney Int 62 2002 245 252 (Pubitemid 34754068)
15. W.N. Suki, R. Zabaneh, and J.L. Cangiano Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients Kidney Int 72 2007 1130 1137 (Pubitemid 47609037)
16. R. Wilson, P. Zhang, M. Smyth, and R. Pratt Assessment of survival in a 2-year comparative study of lanthanum carbonate versus standard therapy Curr Med Res Opin 25 2009 3021 3028
17. V. Autissier, S.J. Damment, and R.A. Henderson Relative in vitro efficacy of the phosphate binders lanthanum carbonate and sevelamer hydrochloride J Pharm Sci 96 2007 2818 2827 (Pubitemid 47597830)
18. A.J. Hutchison Improving phosphate-binder therapy as a way forward Nephrol Dial Transplant 19 suppl 1 2004 i19 i24
19. S.K. Burke, E.A. Slatopolsky, and D.I. Goldberg RenaGel, a novel calcium- and aluminium-free phosphate binder, inhibits phosphate absorption in normal volunteers Nephrol Dial Transplant 12 1997 1640 1644 (Pubitemid 27346290)
20. W. Finn, and I. Kingma-Johnson Urinary phosphorus excretion is a valuable measure of total body phosphorus burden in patients with CKD stages 3 and 4 [ASN abstract TH-PO931] J Am Soc Nephrol 19 2008 320A 321A
21. M.S. Sheikh, J.A. Maguire, and M. Emmett Reduction of dietary phosphorus absorption by phosphorus binders A theoretical, in vitro, and in vivo study J Clin Invest 83 1989 66 73 (Pubitemid 19048406)
22. International Conference on Harmonisation Expert Working Group International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use Topic E6 Guideline for Good Clinical Practice 2002 Geneva, Switzerland: International Conference on Harmonisation http://www.ema.europa.eu/docs/en-GB/document-library/Scientific- guideline/2009/09/WC500002874.pdf Accessed June 17, 2010
23. A.J. Hutchison, B. Maes, and J. Vanwalleghem Long-term efficacy and tolerability of lanthanum carbonate: results from a 3-year study Nephron Clin Pract 102 2006 c61 c71
24. W.Y. Qunibi, R.E. Hootkins, and L.L. McDowell Treatment of hyperphosphatemia in hemodialysis patients: the Calcium Acetate Renagel Evaluation (CARE Study) Kidney Int 65 2004 1914 1926 (Pubitemid 38591044)
25. J. Delmez, G. Block, and J. Robertson A randomized, double-blind, crossover design study of sevelamer hydrochloride and sevelamer carbonate in patients on hemodialysis Clin Nephrol 68 2007 386 391 (Pubitemid 350258767)
26. Shire Pharmaceuticals Fosrenol (lanthanum carbonate) prescribing information (2009) http://pi.shirecontent.com/PI/PDFs/Fosrenol-USA-ENG.pdf Accessed July 13, 2010
27. Genzyme Corp Renvela (sevelamer carbonate) prescribing information (2007) http://www.renagel.com/docs/renvela-pi.pdf. Accessed July 13, 2010
28. G.R. Davis, C.A. Santa Ana, S.G. Morawski, and J.S. Fordtran Development of a lavage solution associated with minimal water and electrolyte absorption or secretion Gastroenterology 78 1980 991 995 (Pubitemid 10120915)
29. US Department of Agriculture Agricultural Research Service USDA National Nutrient Database for Standard Reference, release 21 2008 US Department of Agriculture Beltsville, MD
30. C. Fiske, and Y. Subbarow The colorimetric determination of phosphorus J Biol Chem 66 1925 375 400
31. K.A. Hruska, S. Mathew, R. Lund, P. Qiu, and R. Pratt Hyperphosphatemia of chronic kidney disease Kidney Int 74 2008 148 157 (Pubitemid 351915080)
32. G.R. Davis, J.E. Zerwekh, and T.F. Parker Absorption of phosphate in the jejunum of patients with chronic renal failure before and after correction of vitamin D deficiency Gastroenterology 85 1983 908 916 (Pubitemid 13000645)